Investors in Celldex Therapeutics, Inc. (CLDX - Get Report) saw new options become available this week, for the August 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CLDX options chain for the new August 2018 contracts and identified one put and one call contract of particular interest.The put contract at the $2.00 strike price has a current bid of 35 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $2.00, but will also collect the premium, putting the cost basis of the shares at $1.65 (before broker commissions). To an investor already interested in purchasing shares of CLDX, that could represent an attractive alternative to paying $2.86/share today. Because the $2.00 strike represents an approximate 30% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 82%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 17.50% return on the cash commitment, or 26.62% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Celldex Therapeutics, Inc., and highlighting in green where the $2.00 strike is located relative to that history: Turning to the calls side of the option chain, the call contract at the $4.00 strike price has a current bid of 55 cents. If an investor was to purchase shares of CLDX stock at the current price level of $2.86/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $4.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 59.09% if the stock gets called away at the August 2018 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if CLDX shares really soar, which is why looking at the trailing twelve month trading history for Celldex Therapeutics, Inc., as well as studying the business fundamentals becomes important. Below is a chart showing CLDX's trailing twelve month trading history, with the $4.00 strike highlighted in red: Considering the fact that the $4.00 strike represents an approximate 40% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 58%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 19.23% boost of extra return to the investor, or 29.25% annualized, which we refer to as the YieldBoost. The implied volatility in the put contract example, as well as the call contract example, are both approximately 108%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 253 trading day closing values as well as today's price of $2.86) to be 49%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
More from Stocks
Predictable Fed Cut: Cramer's 'Mad Money' Recap (Wednesday 9/18/19)
The uber-bulls were disappointed, says Jim Cramer. Jay Powell is not a fire-breathing Fed chief, and investors should appreciate that.
Snap CEO Discusses Trends in Company's Recent Turnaround
Evan Spiegel talked about Snap's stock volatility and the company's long-term vision at a Goldman Sachs conference on Wednesday.
Powell Leaves Bears Just Wishing, Hoping and Praying
This was the fourth major news event in the last 10 days that has barely moved the indices.